Millennium Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Millennium Management’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,993	Closed	-$5K	–	7199
2022 Q4	$5K	Buy	+10,993	New	+$11.1K	﹤0.01%	6318
2020 Q4	–	Sell	-12,636	Closed	-$126	–	5718
2020 Q3	$126	Sell	12,636 -3,518	-22%	-$35.4K	﹤0.01%	4185
2020 Q2	$175K	Sell	16,154 -864	-5%	-$8.44K	﹤0.01%	3879
2020 Q1	$124K	Sell	17,018 -934	-5%	-$8.88K	﹤0.01%	3506
2019 Q4	$187K	Sell	17,952 -32,048	-64%	-$322K	﹤0.01%	3898
2019 Q3	$504K	Buy	+50,000	New	+$618K	﹤0.01%	3251
2019 Q2	–	Sell	-27,178	Closed	-$554K	–	4615
2019 Q1	$554K	Sell	27,178 -63,419	-70%	-$1.36M	﹤0.01%	3202
2018 Q4	$1.65M	Buy	90,597 +37,171	+70%	+$897K	﹤0.01%	2311
2018 Q3	$1.41M	Buy	53,426 +34,645	+184%	+$1.01M	﹤0.01%	2670
2018 Q2	$582K	Buy	+18,781	New	+$577K	﹤0.01%	3096
2015 Q3	–	Sell	-81,942	Closed	-$4.26M	–	3822
2015 Q2	$4.26M	Buy	+81,942	New	+$4.41M	0.01%	1489

Other funds holding CYAD

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's CYAD Position: Q1 2023 in Review

Millennium Management sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q1 2023, closing a stake of 10,993 shares — an estimated $5K sold.

Millennium Management first reported a position in CYAD in Q2 2015 and held it in 11 quarters. The position peaked at $4.26M in Q2 2015. 8 funds tracked by Wall St. Rank hold CYAD as of Q1 2023.

Millennium Management reported no remaining Celyad Oncology SA American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 10,993 Celyad Oncology SA American Depositary Shares shares in Q1 2023, an estimated $5K.
Millennium Management first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2015 and held it in 11 quarters.
Millennium Management's Celyad Oncology SA American Depositary Shares position peaked at $4.26M in Q2 2015.
8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.